These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37395684)

  • 21. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.
    Gao Y; Zhang N; Zeng Z; Wu Q; Jiang X; Li S; Sun W; Zhang J; Li Y; Li J; He F; Huang Z; Zhang J; Gong Y; Xie C
    Clin Transl Med; 2022 Apr; 12(4):e792. PubMed ID: 35415876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
    Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
    Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mini-review: the distinct roles of STING signaling in tumor immunity-recent progress.
    Wang S; Li T; Sun H; Chen D; Xu H; Hao J
    J Leukoc Biol; 2023 Jul; 114(2):111-115. PubMed ID: 37141382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer.
    Wei B; Xu L; Guo W; Wang Y; Wu J; Li X; Cai X; Hu J; Wang M; Xu Q; Liu W; Gu Y
    Cancer Res; 2021 Jun; 81(12):3215-3228. PubMed ID: 33820798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.
    Seok JK; Kim M; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2023 Jun; 46(6):500-534. PubMed ID: 37354378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
    Dan Q; Yang Y; Ge H
    Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
    Biolatti M; Dell'Oste V; Pautasso S; Gugliesi F; von Einem J; Krapp C; Jakobsen MR; Borgogna C; Gariglio M; De Andrea M; Landolfo S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer.
    Ka NL; Lim GY; Hwang S; Kim SS; Lee MO
    Cell Rep; 2021 Dec; 37(12):110138. PubMed ID: 34936865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
    Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
    mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cGAS and cancer therapy: a double-edged sword.
    Du JM; Qian MJ; Yuan T; Chen RH; He QJ; Yang B; Ling Q; Zhu H
    Acta Pharmacol Sin; 2022 Sep; 43(9):2202-2211. PubMed ID: 35042992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection.
    Storek KM; Gertsvolf NA; Ohlson MB; Monack DM
    J Immunol; 2015 Apr; 194(7):3236-45. PubMed ID: 25710914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer.
    Yang C; Liang Y; Liu N; Sun M
    Radiat Oncol; 2023 Sep; 18(1):145. PubMed ID: 37667279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
    Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
    Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
    Mondal I; Das O; Sun R; Gao J; Yu B; Diaz A; Behnan J; Dubey A; Meng Z; Eskandar E; Xu B; Lu RO; Ho WS
    Cancer Res; 2023 Aug; 83(15):2527-2542. PubMed ID: 37219874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors.
    Ridnour LA; Cheng RY; Kedei N; Somasundaram V; Bhattacharyya DD; Basudhar D; Wink AL; Walke AJ; Kim C; Heinz WF; Edmondson EF; Butcher DO; Warner AC; Dorsey TH; Pore M; Kinders RJ; Lipkowitz S; Bryant RJ; Rittscher J; Wong ST; Hewitt SM; Chang JC; Shalaby A; Callagy GM; Glynn SA; Ambs S; Anderson SK; McVicar DW; Lockett SJ; Wink DA
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38912586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
    Domizio JD; Gulen MF; Saidoune F; Thacker VV; Yatim A; Sharma K; Nass T; Guenova E; Schaller M; Conrad C; Goepfert C; de Leval L; Garnier CV; Berezowska S; Dubois A; Gilliet M; Ablasser A
    Nature; 2022 Mar; 603(7899):145-151. PubMed ID: 35045565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial Lon protease promotes CD4
    Huang X; Liu Y; Ling G; Cao X
    Int Immunopharmacol; 2023 Oct; 123():110519. PubMed ID: 37531828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.